Resolve Stroke, founded in 2022 and headquartered in France, is pioneering innovations in the AI, Health Care, and Medical Devices sectors. With the slogan "Decode ultrasound data to achieve unparalleled diagnostic performances," the company transforms ultrasound data into vital health insights.
Their mission focuses on solving pressing medical challenges by extracting extensive information from raw ultrasound data using advanced software systems. Resolve Stroke positions itself as a leader in medical imaging, targeting both current applications such as bedside neuro monitoring and future advancements through the discovery of new biomarkers.
In terms of financial backing, Resolve Stroke secured a €2.20M seed investment as of September 1, 2023. This funding round included investments from Kima Ventures, Bpifrance, Quantonation, and OVNI Capital. This infusion of capital signifies strong investor confidence in the company’s potential to revolutionize health technology.